Chemist + Druggist is part of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Two strengths of escitalopram among 19 price concessions for September

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 19 items for September 2019 prescriptions.

An initial 18 prices for the month were announced on September 20.

Drug
Strength
Form
Price
Alverine
60mg
capsules (100)
£9.38
Escitalopram
5mg
tablets (28)
£2.70
Escitalopram
20mg
tablets (28)
£3.72
Hydroxychloroquine
200mg
tablets (60)
£5.25
Indapamide
2.5mg
tablets (28)
£2.89
Irbesartan
150mg
tablets (28)
£5.79
Levetiracetam
500mg
tablets (60)
£8.13
Memantine
20mg
tablets (28)
£8.88
Metoprolol
50mg
tablets (28)
£4.00
Mirtazapine
15mg
tablets (28)
£2.02
Mirtazapine
45mg
tablets (28)
£2.24
Montelukast
10mg
tablets (28)
£3.95
Oxytetracycline
250mg
tablets (28)
£2.50
Pizotifen
1.5mg
tablets (28)
£8.37
Quinine bisulfate
300mg
tablets (28)
£3.50
Tizanidine
2mg
tablets (120)
£11.40
Tolbutamide
500mg
tablets (28)
£14.76
Topiramate
50mg
tablets (60)
£12.14
Valsartan
160mg
capsules (28)
£13.31

Do these reflect the prices you have paid in September so far?

Topics



Pharmacy Dispenser/ Technician
Bethnal Green North, London
Salary: Up to £30,000

Apply Now
UsernamePublicRestriction

Register

CD006109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel